SEED AND BOOST Trademark

Trademark Overview


On Tuesday, November 18, 2025, a trademark application was filed for SEED AND BOOST with the United States Patent and Trademark Office. The USPTO has given the SEED AND BOOST trademark a serial number of 99502227. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Wednesday, July 1, 2026. This trademark is owned by Immunoscape Pte. Ltd.. The SEED AND BOOST trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal preparations and substances for use in oncology; medicinal preparations and substances for the treatment of cancer; medicinal preparations and substances for treating malignant tumours; medicinal preparations and substances for cell therapy; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for treating malignant tumours; biopharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the prevention and treatment of cancer, namely, anti-cancer drugs; pharmaceutical drugs for use in oncology; pharmaceutical drugs for the treatment of cancer; pharmaceutical drugs for treating malignant tumours; injectable pharmaceuticals for use in oncology; injectable pharmaceuticals for the treatment of cancer; injectable pharmaceuticals for treating malignant tumours; cells for medical use; living cells for medical use.
seed and boost

General Information


Serial Number99502227
Word MarkSEED AND BOOST
Filing DateTuesday, November 18, 2025
Status680 - APPROVED FOR PUBLICATION
Status DateWednesday, July 1, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedicinal preparations and substances for use in oncology; medicinal preparations and substances for the treatment of cancer; medicinal preparations and substances for treating malignant tumours; medicinal preparations and substances for cell therapy; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for treating malignant tumours; biopharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the prevention and treatment of cancer, namely, anti-cancer drugs; pharmaceutical drugs for use in oncology; pharmaceutical drugs for the treatment of cancer; pharmaceutical drugs for treating malignant tumours; injectable pharmaceuticals for use in oncology; injectable pharmaceuticals for the treatment of cancer; injectable pharmaceuticals for treating malignant tumours; cells for medical use; living cells for medical use.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 18, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmunoscape Pte. Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressShaw Centre 228208
SG

Trademark Events


Event DateEvent Description
Tuesday, November 18, 2025NEW APPLICATION ENTERED
Tuesday, November 18, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 18, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, March 25, 2026ASSIGNED TO EXAMINER
Wednesday, April 1, 2026NON-FINAL ACTION WRITTEN
Wednesday, April 1, 2026NON-FINAL ACTION E-MAILED
Wednesday, April 1, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 22, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 22, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 22, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 1, 2026APPROVED FOR PUB - PRINCIPAL REGISTER